Iroko

Our Management Team

John F. Vavricka

John F. Vavricka

President and Chief Executive Officer

John Vavricka brings to Iroko over 20 years of broad international experience in the pharmaceutical industry and a demonstrated capacity to build high-performing organizations. Since John co-founded Iroko in 2007, the company has assembled a workforce led by a seasoned management cadre...

read more
Olalekan Andrew Bayode

Olalekan Andrew Bayode

Vice President, North American Commercial Operations

Olalekan Andrew Bayode has over 17 years of worldwide commercial experience.  At Wyeth Pharmaceuticals (now Pfizer Inc), he was Commercial Director, Europe/Middle East/Africa/Canada, in the Pharmaceutical Global Business Unit. He also served as Commercial Director for the rheumatology ...

read more
Humphrey J. Harte

Humphrey J. Harte

Senior Vice President of Commercial Operations, Europe & Int

Humphrey Harte has more than 20 years of sales and marketing experience in both established and start-up companies in various countries. He was Vice-President, Commercial Operations, Europe and General Manager UK, at Novartis Vaccines. Prior to this he was a member of the Senior...

read more
Paul Hemsley

Paul Hemsley

Senior Vice President, Strategy and Project Planning

Paul Hemsley has more than 20 years of experience in pharmaceutical companies and consulting firms. He was Vice President, Global Strategic Planning, and Vice President, Marketing, at Novartis (formerly Chiron) Vaccines. Earlier, as a management consultant, he advised life-sciences companies on commercial and R&D strategy...

read more
E. Olaolu Imasogie MD

E. Olaolu Imasogie MD

Vice President, Pharmacovigilance & Medical Information

Olaolu Imasogie has more than 20 years of experience in medicine, information technology, and the pharmaceutical industry.At GlaxoSmithKline he designed continuing-medical-education programs for the metabolic therapeutic area and worked in Medical Information and Medical Affairs. Earlier, he served as...

read more
Moji James

Moji James

General Counsel and Vice President

Moji James has two decades of experience in the practice of law, during which time she has supported the development and launch of high-profile drugs, biologics and vaccines.

read more
Steve Jensen

Steve Jensen

Vice President, Regulatory Affairs and Compliance

Steve Jensen is a senior regulatory professional with nearly 20 years of industry experience leading U.S. and international development and post-marketing programs. He was a principal advisor and a co-founder at Laurus Regulatory Advisors, a pharma/biotech consulting firm specializing...

read more
Fred C. Krieger

Fred C. Krieger

Chief Financial Officer

Fred Krieger has more than 30 years of experience managing a wide array of financial functions in international pharmaceutical companies. He served as Vice President, Financial Control, Planning and Reporting, at GlaxoSmithKline Pharmaceuticals Research & Development. There he directed...

read more
Ariyapadi N. Krishnaraj

Ariyapadi N. Krishnaraj

Vice President, New Product Development

Ariyapadi Krishnaraj has more than 20 years of sales and marketing experience in the pharmaceutical industry.He was Senior Vice President, Healthcare Analytics, for Genpact, Inc. There he led the building of the analytics-services business while serving such clients as  GlaxoSmithKline, Pfizer, Johnson and Johnson...

read more
Rohit C. Mehta

Rohit C. Mehta

Senior Vice President, Corporate Development & Alliance Mgmt

Rohit Mehta has nearly 20 years of experience across a broad range of business-development activities, including licensing, product acquisitions, M&A due diligence, joint ventures, and technology assessment. He was a principal in Jay Consulting, a firm providing business and...

read more
Fran Rhoades

Fran Rhoades

Director, Human Resources

Fran Rhoades is a senior human resources professional with over 20 years experience in her field. She has served as Director, Human Resources and Payroll, at Delaware Valley College, and as Associate Director, Human Resources, at the Wharton School of the University...

read more
Clarence L. Young M.D.

Clarence L. Young, M.D.

Chief Medical Officer

Dr. Clarence L. Young has nearly 25 years of drug development and research experience from the pharmaceutical industry as well as academia. Over the course of his career he has provided medical oversight of numerous clinical trials, regulatory filings, and product launches.

Prior to joining Iroko, he was Vice President Targeted Therapies and Integrated Hospital Care at Novartis Pharmaceuticals Corporation, responsible for leading cross-functional teams in development, global registration and commercialization of small and large molecules.

read more